Lexicon Pharma (LXRX) Tops Q3 EPS by 3c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.36 -3.67%
Financial Fact:
Collaborative research: 27.69M
Today's EPS Names:
GEOS, ARTNA, REFR, More
Financial Fact:
Collaborative research: 27.69M
Today's EPS Names:
GEOS, ARTNA, REFR, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q3 EPS of ($0.04), $0.03 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $14.1 million versus the consensus estimate of $4.65 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nutex Health (NUTX) Tops Q2 EPS by 450c
- Kodiak Gas Services, Inc. (KGS) Reports Q2 EPS of $0.55
- Nelnet (NNI) Misses Q2 EPS by 36c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
